An infrastructure for interconnecting research institutions

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Many researchers believe that personalized medicine is a potential solution to the well-known challenges facing the pharmaceutical industry worldwide today. Achieving the full promise of personalized medicine requires a new systems approach to biomedicine that will only be enabled by novel, interoperable IT infrastructures that facilitate simpler data access, data sharing, and enhanced collaboration. This article will describe how the technology developed in the cancer Biomedical Informatics Grid® (caBIG®) program (http://cabig.cancer.gov/) from the National Cancer Institute (NCI) is already enabling many research organizations to implement personalized medicine approaches for their basic and clinical research programs.

Original languageEnglish (US)
Pages (from-to)605-610
Number of pages6
JournalDrug Discovery Today
Volume14
Issue number11-12
DOIs
StatePublished - Jun 2009
Externally publishedYes

Fingerprint

Precision Medicine
Research
Informatics
National Cancer Institute (U.S.)
Information Dissemination
Drug Industry
Systems Analysis
Research Personnel
Organizations
Technology
Neoplasms

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology

Cite this

An infrastructure for interconnecting research institutions. / Buetow, Kenneth.

In: Drug Discovery Today, Vol. 14, No. 11-12, 06.2009, p. 605-610.

Research output: Contribution to journalArticle

@article{0e14216756e2447b80003bf682c0f0fd,
title = "An infrastructure for interconnecting research institutions",
abstract = "Many researchers believe that personalized medicine is a potential solution to the well-known challenges facing the pharmaceutical industry worldwide today. Achieving the full promise of personalized medicine requires a new systems approach to biomedicine that will only be enabled by novel, interoperable IT infrastructures that facilitate simpler data access, data sharing, and enhanced collaboration. This article will describe how the technology developed in the cancer Biomedical Informatics Grid{\circledR} (caBIG{\circledR}) program (http://cabig.cancer.gov/) from the National Cancer Institute (NCI) is already enabling many research organizations to implement personalized medicine approaches for their basic and clinical research programs.",
author = "Kenneth Buetow",
year = "2009",
month = "6",
doi = "10.1016/j.drudis.2009.03.011",
language = "English (US)",
volume = "14",
pages = "605--610",
journal = "Drug Discovery Today",
issn = "1359-6446",
publisher = "Elsevier Limited",
number = "11-12",

}

TY - JOUR

T1 - An infrastructure for interconnecting research institutions

AU - Buetow, Kenneth

PY - 2009/6

Y1 - 2009/6

N2 - Many researchers believe that personalized medicine is a potential solution to the well-known challenges facing the pharmaceutical industry worldwide today. Achieving the full promise of personalized medicine requires a new systems approach to biomedicine that will only be enabled by novel, interoperable IT infrastructures that facilitate simpler data access, data sharing, and enhanced collaboration. This article will describe how the technology developed in the cancer Biomedical Informatics Grid® (caBIG®) program (http://cabig.cancer.gov/) from the National Cancer Institute (NCI) is already enabling many research organizations to implement personalized medicine approaches for their basic and clinical research programs.

AB - Many researchers believe that personalized medicine is a potential solution to the well-known challenges facing the pharmaceutical industry worldwide today. Achieving the full promise of personalized medicine requires a new systems approach to biomedicine that will only be enabled by novel, interoperable IT infrastructures that facilitate simpler data access, data sharing, and enhanced collaboration. This article will describe how the technology developed in the cancer Biomedical Informatics Grid® (caBIG®) program (http://cabig.cancer.gov/) from the National Cancer Institute (NCI) is already enabling many research organizations to implement personalized medicine approaches for their basic and clinical research programs.

UR - http://www.scopus.com/inward/record.url?scp=67349223909&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349223909&partnerID=8YFLogxK

U2 - 10.1016/j.drudis.2009.03.011

DO - 10.1016/j.drudis.2009.03.011

M3 - Article

C2 - 19508923

AN - SCOPUS:67349223909

VL - 14

SP - 605

EP - 610

JO - Drug Discovery Today

JF - Drug Discovery Today

SN - 1359-6446

IS - 11-12

ER -